FDA To Review NDA For Liquidia's Yutrepia
25/9 23:06
(RTTNews) - Liquidia Corporation (LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's amendment to the tentatively approved new drug application for Yutrepia (treprostinil) inhalation powder in which the company is seeking to a...